Schedule 13G ownership disclosure

BIORA THERAPEUTICS INC

Biora Therapeutics, Inc. Common Stock · CUSIP: 74319F305

Event date: 2024-03-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Context Capital Management, LLC

    Shares: 2,989,698.00 · Class: 9.9%

  • Michael S. Rosen

    Shares: 2,989,698.00 · Class: 9.9%

  • William D. Fertig

    Shares: 2,989,698.00 · Class: 9.9%

  • Charles E. Carnegie

    Shares: 2,989,698.00 · Class: 9.9%

  • Context Partners Master Fund, L.P.

    Shares: 2,989,698.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001301396-24-000005
Form type
SCHEDULE 13G
Filer
BIORA THERAPEUTICS, INC.
CIK
CIK 1580063
Filed
Mar 20, 2024
Reporting period
Mar 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub